X4 Pharmaceuticals: Q2 Earnings Insights

X4 Pharmaceuticals XFOR reported its Q2 earnings results on Thursday, August 4, 2022.

Here's what investors need to know about the announcement.

Earnings

X4 Pharmaceuticals beat estimated earnings by 6.25%, reporting an EPS of $-0.6 versus an estimate of $-0.64.

Revenue was down $0 from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.11 which was followed by a 15.38% increase in the share price the next day.

To track all earnings releases for X4 Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.